ProQR Therapeutics PRQR
NASDAQ PRQR
$1.26 -0.05 (-3.82%)
At close: Nov 11, 2026 · 4:00 PM EST

ProQR Therapeutics (PRQR) EV to CFO (2023)

Updated

ProQR Therapeutics' EV to CFO came in at 1.45 for the quarter ended Dec 31, 2023.

Analysis

ProQR Therapeutics (PRQR) EV to CFO (2023) Analysis & Trends

For the year ended Dec 31, 2023, ProQR Therapeutics' EV to CFO was 1.34.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 ProQR Therapeutics 138.02 Mn -322.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.29
Sep 30, 2023 -2.15
Jun 30, 2023 -3.21
API Access

ProQR Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PRQR&period=max&api_key=YOUR_API_KEY